Search research articles
Contact Us
Filters
Showing results (11-20 of 134) with videos related to
Page
of 14
Sort By:
Neuro-Degenerative Diseases
|
July 14, 2007
Stem-cell-based strategies for the treatment of Parkinson's disease
Clare L Parish, Ernest Arenas
Neuro-Degenerative Diseases
|
August 16, 2006
Function of Wnts in dopaminergic neuron development
Gonçalo Castelo-Branco, Ernest Arenas
Experimental Neurology
|
January 12, 2010
Transplantable midbrain dopamine neurons: a moving target
J Carlos Villaescusa, Ernest Arenas
Cellular Signalling
|
October 10, 2006
Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin
Vítezslav Bryja, Gunnar Schulte, Ernest Arenas
Nature Protocols
|
May 10, 2007
Derivation of mouse embryonic stem cells
Vítezslav Bryja, Sonia Bonilla, Ernest Arenas
Springerplus
|
July 8, 2016
WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson's disease
Ernest Arenas, Carmen Saltó, Carlos Villaescusa
Journal of Cell Science
|
November 4, 2004
GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons
Gonçalo Castelo-Branco, Nina Rawal, Ernest Arenas
British Journal of Pharmacology
|
May 27, 2017
Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease
Enrique M Toledo, Daniel Gyllborg, Ernest Arenas
Experimental Cell Research
|
April 19, 2008
The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons
Linda C Edman, Helena Mira, Ernest Arenas
Development (Cambridge, England)
|
May 28, 2015
How to make a midbrain dopaminergic neuron
Ernest Arenas, Mark Denham, J Carlos Villaescusa
Page
of 14
Search research articles
Search
Showing results (11-20 of 134) with videos related to
Sort By:
Page
of 14
Neuro-Degenerative Diseases
|
July 14, 2007
Stem-cell-based strategies for the treatment of Parkinson's disease
Clare L Parish, Ernest Arenas
Neuro-Degenerative Diseases
|
August 16, 2006
Function of Wnts in dopaminergic neuron development
Gonçalo Castelo-Branco, Ernest Arenas
Experimental Neurology
|
January 12, 2010
Transplantable midbrain dopamine neurons: a moving target
J Carlos Villaescusa, Ernest Arenas
Cellular Signalling
|
October 10, 2006
Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin
Vítezslav Bryja, Gunnar Schulte, Ernest Arenas
Nature Protocols
|
May 10, 2007
Derivation of mouse embryonic stem cells
Vítezslav Bryja, Sonia Bonilla, Ernest Arenas
Springerplus
|
July 8, 2016
WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson's disease
Ernest Arenas, Carmen Saltó, Carlos Villaescusa
Journal of Cell Science
|
November 4, 2004
GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons
Gonçalo Castelo-Branco, Nina Rawal, Ernest Arenas
British Journal of Pharmacology
|
May 27, 2017
Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease
Enrique M Toledo, Daniel Gyllborg, Ernest Arenas
Experimental Cell Research
|
April 19, 2008
The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons
Linda C Edman, Helena Mira, Ernest Arenas
Development (Cambridge, England)
|
May 28, 2015
How to make a midbrain dopaminergic neuron
Ernest Arenas, Mark Denham, J Carlos Villaescusa
Page
of 14